Cardiovascular Disease Prevention in People with HIV: Past, Present and Future

Cardiovascular disease (CVD) is increased among PWH. The presentation of CVD among PWH is often unique compared to the general population. Epidemiologic studies suggest that CVD often occurs among younger PWH, with higher relative rates among females. Moreover, CVD often presents with lower predicted risk than in the general population of disease, using current risk prediction algorithms. Prior studies suggest increased patterns of inflammation and vulnerable coronary plaque among PWH, which may be amenable to lipid and inflammation lowering strategies. New data from the global REPRIEVE trial reinforce the utility of a statin prevention trial for low-moderate risk PWH, highlight optimal treatment groups, and demonstrate unique mechanisms of cardiovascular disease as well as novel strategies for future study in this population.

MODERATOR: Markella Zanni, MD, Associate Professor of Medicine, HMS
RSVP TO ATTEND: https://harvard.zoom.us/webinar/register/WN_74LlrYfmS9Sa-PdwwlODFQ#/registration
SPEAKERS: Virginia (Jeanne) Triant, MD, MPH, Assistant Professor of Medicine, HMS & Steven Grinspoon, MD, Professor of Medicine, HMS